Search results
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 5 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 3 days agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...
Cramer's Lightning Round: 'Let's stay away' from Unity Software
CNBC· 6 days ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 3 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day...
Benzinga· 6 days agoShares of AMMO, Inc. POWW fell sharply during Friday's session following fourth-quarter results....
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 5 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration (FDA) announced ...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 6 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 6 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day...
Benzinga· 2 days agoShares of Quantum Corporation QMCO fell sharply during Tuesday's session after the company reported...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 5 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain of the JN.1 variant ...